Angel Bridge

Angel Bridge Co., Ltd. is an investment firm based in Tokyo, Japan, founded in 2015. The firm specializes in principal investments across various sectors, including early-stage and pre-startup companies. It aims to provide substantial funding, investing up to JPY 1 billion in each portfolio company. Angel Bridge primarily focuses on exiting its investments through initial public offerings or mergers and acquisitions. The firm is recognized for offering high-quality financial support to promising businesses, particularly in the technology sector.

Masayoshi Hayashi

Partner

14 past transactions

Logomix Inc.

Seed Round in 2023
Logomix is a pioneering synthetic biology company. With its unprecedented genome engineering platform, Geno-Writing™, Logomix facilitates precise and Mb-scale manipulation of genomic sequences within human cells, leads the development of super-functionalized hypoimmune cells to address critical limitations in contemporary cell therapy approaches, and unlocks the potential with a TAM of solid tumors and 70,000 genetic diseases worth trillion of dollars.

SmartRyde

Series A in 2021
We are SmartRyde, a young and ambitious fast-growing start-up. Our platform is solely focused on airport transfer services, helping make travel truly comfortable. SmartRyde not only builds upon existing transportation suppliers around the world, all into one single, unique platform but also connects them to online travel agencies (OTA). As of August 2021, we have collaborated with more than 650 transportation operators and more than 25 OTAs, including top global players such as Booking.com, Expedia, Trip.com, Traveloka, and Despegar.

BluAge

Series A in 2020
BluAge is a company that specializes in developing room search application. It has developed Canary, a service that provides fast and easy room search. BluAge was founded on April 16, 2018.

KYC Consulting

Seed Round in 2020
KYC Consulting Corporation provides risk management and KYC internal system construction services. They also offer a range of services, including the creation and maintenance of KYC manuals, employee training on KYC compliance, and practical assistance with KYC operations.

Theoria Science

Venture Round in 2019
Theoria Science is an exosome research company. Theoria Science develops cancer diagnostic and therapeutic methods using exosomes. Their business categories include inspections, reagents, and health checkup services.

KYC Consulting

Seed Round in 2019
KYC Consulting Corporation provides risk management and KYC internal system construction services. They also offer a range of services, including the creation and maintenance of KYC manuals, employee training on KYC compliance, and practical assistance with KYC operations.

DIRIGIO

Seed Round in 2019
DIRIGIO is an Operation and development of mobile order & pay platform.

SmartRyde

Seed Round in 2018
We are SmartRyde, a young and ambitious fast-growing start-up. Our platform is solely focused on airport transfer services, helping make travel truly comfortable. SmartRyde not only builds upon existing transportation suppliers around the world, all into one single, unique platform but also connects them to online travel agencies (OTA). As of August 2021, we have collaborated with more than 650 transportation operators and more than 25 OTAs, including top global players such as Booking.com, Expedia, Trip.com, Traveloka, and Despegar.

Fukushima SiC Applied Engineering

Venture Round in 2018
Fukushima SiC Applied Engineering is a manufacturer of silicon carbide semiconductor devices for the medical and industrial fields. Using this SiC device, Fukushima SiC Applied Engineering Research Institute has the technology to design and manufacture circuits that handle high voltages and currents ranging from 10 KV to several hundred kV and 10 A to 1000 A. The company commercializes a circuit that uses a series resonance circuit to achieve high output and stability.

Ondeck

Venture Round in 2018
ONDEC pursues advice services focusing on the "people" involved in the company's concepts and history. Many SME M&As begin on the "transfer side (selling side)," which is primarily concerned with succession issues. As a result, there are several support companies that specialize solely on "matching" to discover a suitable acquisition company.

Heartseed

Series A in 2018
Heartseed has set a mission to “open the door to heart disease treatment with regenerative medicine” and is working toward the day-to-day clinical application of myocardial regenerative medicine.

Heartseed

Seed Round in 2016
Heartseed has set a mission to “open the door to heart disease treatment with regenerative medicine” and is working toward the day-to-day clinical application of myocardial regenerative medicine.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.